Moran Kyle 4
4 · Wave Life Sciences Ltd. · Filed Oct 11, 2024
Insider Transaction Report
Form 4
Moran Kyle
Chief Financial Officer
Transactions
- Exercise/Conversion
Share Option (right to buy)
2024-10-11−25,000→ 0 totalExercise: $2.48Exp: 2025-03-10→ Ordinary Shares (25,000 underlying) - Exercise/Conversion
Ordinary Shares
2024-10-11$2.48/sh+25,000$62,000→ 44,777 total
Footnotes (1)
- [F1]The share options that were exercised via cash purchase in this reportable transaction were fully vested.